Hospital/Health-System Pharmacy Medication adherence: High tech still needs a personal touch September 09, 2016 By Marc O'Connor Where do the capabilities of healthcare technology end and the need for the human hand begin to deliver top value for managed care executives? Remicade will now have a biosimilar August 24, 2016 By Tracey Walker Expert: Expectations are high that biosimilars can control overall biologic cost growth. Top 5 skills for an ACO liaison As ACOs continue to grow in the healthcare sector, it is imperative that a liaison is in place to act as an intermediary between ACO members and patients to help achieve desired outcomes. Up for debate: CMS Star Ratings released August 03, 2016 By Tracey Walker Experts break down the controversy over the agency’s release of Overall Hospital Quality Star Ratings. Here's what docs don't know about diabetes patients August 01, 2016 By Tracey Walker Surveys conducted by the AACE with support from Sanofi US, identified differences in perceptions among adults living with type 2 diabetes. What healthcare professionals don't know may surprise you. HHS tackles opioid epidemic July 09, 2016 By Tracey Walker HHS is taking formal steps to address opioid addiction, a widely recognized national public health crisis. Find out the policy changes. Antibiotic stewardship programs: 4 case studies July 06, 2016 By Tracey Walker All antibiotic use has the potential to contribute to the development of antibiotic resistance. That’s why it is key to reduce inappropriate antibiotic use in order to slow the growth of resistance. How health plans can derail ER care costs June 16, 2016 By Tracey Walker The ER Savings Initiative is designed to deliver care in a hybrid model that collaborates with health systems to eliminate the unnecessary use and costs of their ERs. New agreement supports value-based pharma contracting June 01, 2016 By Tracey Walker Industry experts are using their proprietary data/analysis to help structure contracts between pharmaceutical companies and plans. Four critical components for successful, value-based pharma contracts June 01, 2016 By Marc O'Connor Despite their proliferation, at-risk pharma contracts are still little more than value-based window dressing. Here are four critical components of contracts that can actually move the value meter in the right direction.